BioCardia, Inc. (NASDAQ:BCDA) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET
Company Participants
Miranda Peto – Investor Relations
Peter Altman – President and CEO
David McClung – Chief Financial Officer
Conference Call Participants
Joe Pantginis – H.C. Wainwright
Kumar Raja – Brookline Capital Markets
Operator
Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the BioCardia Third Quarter 2024 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]
Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately one hour after the end of the call.
I would now like to turn the floor over to Miranda Peto of BioCardia Investor Relations. Please go ahead, Miranda.
Miranda Peto
Thank you. Good afternoon and thank you for participating in today’s conference call. Joining me from BioCardia’s leadership team are Peter Altman, President and Chief Executive Officer; and David McClung, the company’s Chief Financial Officer.
During this call, management will be making forward-looking statements, including statements that address BioCardia’s expectations for future performance and operational results, references to management’s intentions, beliefs, projections, outlook, analyses and current expectations.
Such factors include, among others, the inherent uncertainties associated with developing new product technologies and obtaining regulatory approvals. Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements.
For more information about these risks, please refer to the risk factors and cautionary statements described in BioCardia’s report on Form 10-K, filed with the SEC on March 27, 2024, and in subsequently filed Form 10-Qs.
Read the full article here
